Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors-Reference-Cited by-同舟云学术

Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors

Published:2012-09-14 Issue:11 Volume:103 Page:1946-1954
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Minakata Kunihiko,Takahashi Fumiyuki,Nara Takeshi¹,Hashimoto Muneaki¹,Tajima Ken,Murakami Akiko,Nurwidya Fariz,Yae Suzu,Koizumi Fumiaki²,Moriyama Hiroyuki³,Seyama Kuniaki,Nishio Kazuto⁴,Takahashi Kazuhisa

Affiliation:

1. Department of Molecular and Cellular Parasitology; School of Medicine; Juntendo University; Tokyo; Japan

2. Shien-Lab; National Cancer Center Hospital; Tokyo; Japan

3. Pharmaceutical Research and Technology Institute; School of Medicine; Kinki University; Osaka; Japan

4. Department of Genome Biology; School of Medicine; Kinki University; Osaka; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2012.02408.x/fullpdf

Reference28 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression;Ohsaki;Oncol Rep,2000

3. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis;Hirsch;J Clin Oncol,2003

4. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat Rev Cancer,2007

5. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

2. Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer;BMC Complementary Medicine and Therapies;2024-06-05

3. Mechanistic Prediction and validation of Brevilin A Therapeutic Effects in Lung Cancer;2024-03-06

4. Design and investigation of interactions of novel peptide conjugates of purine and pyrimidine derivatives with EGFR and its mutant T790M/L858R: an in silico and laboratory study;Molecular Diversity;2024-01-19

5. Evaluation of AMG510 Therapy on KRAS-Mutant Non–Small Cell Lung Cancer and Colorectal Cancer Cell Using a 3D Invasive Tumor Spheroid System under Normoxia and Hypoxia;Bioengineering;2022-12-12